Hypoglycemia Risk With SGLT2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists Versus Sulfonylureas Among Medicare Insured Adults With CKD in the United States-Reference-Cited by-同舟云学术

Hypoglycemia Risk With SGLT2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists Versus Sulfonylureas Among Medicare Insured Adults With CKD in the United States

Published:2022-08 Issue:8 Volume:4 Page:100510
ISSN:2590-0595
Container-title:Kidney Medicine
language:en
Short-container-title:Kidney Medicine

Author:

Zhao Julie Z.,Weinhandl Eric D.,Carlson Angeline M.,St. Peter Wendy L.

Funder

Centers for Medicare and Medicaid Services

Publisher

Elsevier BV

Subject

Nephrology,Internal Medicine

Reference26 articles.

1. Mechanisms of seizures and coma in hypoglycemia. Evidence for a direct effect of insulin on electrolyte transport in brain;Arieff;J Clin Invest,1974

2. Hypoglycemia and risk of seizures: a retrospective cross-sectional study;Imad;Seizure,2015

3. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring;Desouza;Diabetes Care,2003

4. Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications;Gerich;Diabet Med,2010

5. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study;Miller;BMJ,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between clinical and laboratory factors and response to sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes: a retrospective observational study;Expert Opinion on Pharmacotherapy;2024-05-23

2. Type 2 Diabetes and Chronic Kidney Disease: An Opportunity for Pharmacists to Improve Outcomes;Journal of Clinical Medicine;2024-02-28

3. Expert consensus recommendations on the evaluation and management of hypoglycemia in diabetes: DGENius Group Diabetes India;Journal of Diabetology;2024-01

4. The Role of Sodium-Glucose Cotransporter-2 Inhibitors in the Treatment Paradigm of CKD in Africa: An African Association of Nephrology Panel Position Paper;Kidney International Reports;2023-12

5. HbA1c‐dependent projection of long‐term renal outcomes;Journal of Internal Medicine;2023-11-05